(Circulation. 2000;101:1679.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
Myofilament Calcium Regulation in Human Myocardium
From the Cardiology Division (R.J.H., U.S.), Massachusetts General Hospital and Boston University School of Medicine (C.S.K., A.A.D., J.K.G.), Boston, Mass; Gwathmey Inc (C.S.K., D.L., A.A.D., J.K.G.), Cambridge, Mass; and the Laboratory of Muscle Research and Molecular Cardiology (R.H.G.S., U.S.), Clinic III of Internal Medicine, University of Cologne.
Correspondence to Judith K. Gwathmey, VMD, PhD, FACC, 763 Concord Ave, Building E, Cambridge, MA 02138. E-mail: gwathmey{at}earthlink.net
Background—We investigated whether decreased myofilament calcium contractile activation may, in part, contribute to heart failure.
Methods and Results—Calcium concentration required for 50% activation and Hill coefficient for fibers from nonfailing and failing human hearts at pH 7.1 were not different. Maximum calcium-activated force (Fmax) was also not different. However, at pH 6.8 and 6.9, differences were seen in myofilament calcium activation between nonfailing and failing hearts. At lower pH, failing myocardium was shifted left on the calcium axis compared with nonfailing myocardium, which suggested an increase in myofilament calcium responsiveness. Increased inorganic phosphate concentration decreased maximal force development by 56% in nonfailing and 36% in failing myocardium and shifted the calcium-force relationship by 2.01±0.22 versus 0.86±0.13 µmol/L, respectively (P<0.05). Addition of cAMP resulted in a 0.56 µmol/L shift toward higher intracellular calcium concentrations in nonfailing myocardium and a 1.04 µmol/L shift in failing myocardium. Protein kinase A in the presence of cAMP resulted in a further rightward shift in nonfailing human myocardium but did not further shift the calcium-force relationship in fibers from failing hearts. cGMP also resulted in a greater decrease in myofilament calcium sensitivity in fibers from failing hearts.
Conclusions—We propose that changes at the level of the thin myofilaments result in differential responses to changes in the intracellular milieu in nonfailing versus failing myocardium.
Key Words: myocardium • heart failure • calcium • cGMP • myocytes
This article has been cited by other articles:
 |
|
 |
|
  J. Layland, R. J. Solaro, and A. M. Shah Regulation of cardiac contractile function by troponin I phosphorylation Cardiovasc Res, April 1, 2005; 66(1): 12 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Mundina-Weilenmann, P. Ferrero, M. Said, L. Vittone, E. G. Kranias, and A. Mattiazzi Role of phosphorylation of Thr17 residue of phospholamban in mechanical recovery during hypercapnic acidosis Cardiovasc Res, April 1, 2005; 66(1): 114 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Linz, G. Itter, L. W Dobrucki, T. Malinski, and G. Wiemer Ramipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction Journal of Renin-Angiotensin-Aldosterone System, September 1, 2003; 4(3): 180 - 185. [Abstract] [PDF]
|
|
|
|
 |
|
 S. R. Houser and K. B. Margulies Is Depressed Myocyte Contractility Centrally Involved in Heart Failure? Circ. Res., March 7, 2003; 92(4): 350 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. del Monte and R. J Hajjar Targeting calcium cycling proteins in heart failure through gene transfer J. Physiol., January 1, 2003; 546(1): 49 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Petretta, M. L.E. Vicario, L. Spinelli, A. Ferro, A. Cuocolo, M. Condorelli, and D. Bonaduce Combined effect of the force-frequency and length-tension mechanisms on left ventricular function in patients with dilated cardiomyopathy Eur J Heart Fail, December 1, 2002; 4(6): 727 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Robinson, M. Mirza, A. Knott, H. Abdulrazzak, R. Willott, S. Marston, H. Watkins, and C. Redwood Alterations in Thin Filament Regulation Induced by a Human Cardiac Troponin T Mutant That Causes Dilated Cardiomyopathy Are Distinct from Those Induced by Troponin T Mutants That Cause Hypertrophic Cardiomyopathy J. Biol. Chem., October 18, 2002; 277(43): 40710 - 40716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Communal, M. Sumandea, P. de Tombe, J. Narula, R. J. Solaro, and R. J. Hajjar Functional consequences of caspase activation in cardiac myocytes PNAS, April 18, 2002; (2002) 92022999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Loennechen, U. Wisloff, G. Falck, and O. Ellingsen Effects of Cariporide and Losartan on Hypertrophy, Calcium Transients, Contractility, and Gene Expression in Congestive Heart Failure Circulation, March 19, 2002; 105(11): 1380 - 1386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. van der Velden, L.J. Klein, R. Zaremba, N.M. Boontje, M.A.J.M. Huybregts, W. Stooker, L. Eijsman, J.W. de Jong, C.A. Visser, F.C. Visser, et al. Effects of Calcium, Inorganic Phosphate, and pH on Isometric Force in Single Skinned Cardiomyocytes From Donor and Failing Human Hearts Circulation, September 4, 2001; 104(10): 1140 - 1146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Suematsu, S. Satoh, S. Kinugawa, H. Tsutsui, S. Hayashidani, R. Nakamura, K. Egashira, N. Makino, and A. Takeshita {alpha}1-Adrenoceptor-Gq-RhoA signaling is upregulated to increase myofibrillar Ca2+ sensitivity in failing hearts Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H637 - H646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Communal, M. Sumandea, P. de Tombe, J. Narula, R. J. Solaro, and R. J. Hajjar Functional consequences of caspase activation in cardiac myocytes PNAS, April 30, 2002; 99(9): 6252 - 6256. [Abstract] [Full Text] [PDF]
|
|